Biogen Pharmachem Industries Limited (BOM:531752)
India
· Delayed Price · Currency is INR 0.620
-0.010 (-1.59%)
At close: Mar 9, 2026
BOM:531752 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 20.16 | 0.17 | 1.29 | 0.83 | 0.07 | Upgrade
|
| Cash & Short-Term Investments | 3.65 | 20.16 | 0.17 | 1.29 | 0.83 | 0.07 | Upgrade
|
| Cash Growth | 13.04% | 11830.77% | -86.87% | 54.69% | 1018.46% | 122.17% | Upgrade
|
| Accounts Receivable | - | - | - | - | - | 25.4 | Upgrade
|
| Other Receivables | - | 5.67 | - | - | 18.4 | - | Upgrade
|
| Receivables | - | 5.67 | - | - | 18.4 | 25.4 | Upgrade
|
| Other Current Assets | - | 0.85 | 0.75 | 0.25 | 0.11 | 0.11 | Upgrade
|
| Total Current Assets | - | 26.69 | 0.92 | 1.54 | 19.34 | 25.58 | Upgrade
|
| Long-Term Investments | - | 238.44 | 54.43 | 88.53 | 69.53 | 94.92 | Upgrade
|
| Other Long-Term Assets | - | -0 | - | - | - | - | Upgrade
|
| Total Assets | - | 920.18 | 568.22 | 548.28 | 549.5 | 542.51 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 0.61 | Upgrade
|
| Other Current Liabilities | - | 0.9 | 3.02 | 2.38 | 8.15 | 0.47 | Upgrade
|
| Total Current Liabilities | - | 0.9 | 3.02 | 2.38 | 8.15 | 1.08 | Upgrade
|
| Total Liabilities | - | 0.9 | 3.02 | 2.38 | 8.15 | 1.08 | Upgrade
|
| Common Stock | - | 652.6 | 652.6 | 652.6 | 652.6 | 652.6 | Upgrade
|
| Retained Earnings | - | -90.33 | -87.4 | -106.71 | -111.26 | -111.18 | Upgrade
|
| Comprehensive Income & Other | - | 357 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 990.81 | 919.28 | 565.2 | 545.9 | 541.34 | 541.43 | Upgrade
|
| Total Liabilities & Equity | - | 920.18 | 568.22 | 548.28 | 549.5 | 542.51 | Upgrade
|
| Total Debt | - | - | - | - | - | 0.61 | Upgrade
|
| Net Cash (Debt) | 3.65 | 20.16 | 0.17 | 1.29 | 0.83 | -0.53 | Upgrade
|
| Net Cash Growth | 13.04% | 11830.77% | -86.87% | 54.69% | - | - | Upgrade
|
| Net Cash Per Share | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | -0.00 | Upgrade
|
| Filing Date Shares Outstanding | 462.3 | 652.6 | 652.6 | 652.6 | 652.6 | 652.6 | Upgrade
|
| Total Common Shares Outstanding | 462.3 | 652.6 | 652.6 | 652.6 | 652.6 | 652.6 | Upgrade
|
| Working Capital | - | 25.79 | -2.1 | -0.84 | 11.19 | 24.5 | Upgrade
|
| Book Value Per Share | 2.02 | 1.41 | 0.87 | 0.84 | 0.83 | 0.83 | Upgrade
|
| Tangible Book Value | 990.81 | 919.28 | 565.2 | 545.9 | 541.34 | 541.43 | Upgrade
|
| Tangible Book Value Per Share | 2.02 | 1.41 | 0.87 | 0.84 | 0.83 | 0.83 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.